ETNB
Price
$8.91
Change
-$0.00 (-0.00%)
Updated
Nov 14, 03:19 PM (EDT)
125 days until earnings call
IDYA
Price
$29.97
Change
-$0.52 (-1.71%)
Updated
Nov 14, 03:25 PM (EDT)
138 days until earnings call
Ad is loading...

ETNB vs IDYA

Header iconETNB vs IDYA Comparison
Open Charts ETNB vs IDYABanner chart's image
89bio
Price$8.91
Change-$0.00 (-0.00%)
Volume$100
CapitalizationN/A
IDEAYA Biosciences
Price$29.97
Change-$0.52 (-1.71%)
Volume$494
CapitalizationN/A
ETNB vs IDYA Comparison Chart
Loading...
ETNB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
IDYA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ETNB vs. IDYA commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETNB is a Hold and IDYA is a StrongSell.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (ETNB: $8.91 vs. IDYA: $30.49)
Brand notoriety: ETNB and IDYA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ETNB: 420% vs. IDYA: 59%
Market capitalization -- ETNB: $946.12M vs. IDYA: $2.64B
ETNB [@Biotechnology] is valued at $946.12M. IDYA’s [@Biotechnology] market capitalization is $2.64B. The market cap for tickers in the [@Biotechnology] industry ranges from $473.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ETNB’s FA Score shows that 0 FA rating(s) are green whileIDYA’s FA Score has 1 green FA rating(s).

  • ETNB’s FA Score: 0 green, 5 red.
  • IDYA’s FA Score: 1 green, 4 red.
According to our system of comparison, ETNB is a better buy in the long-term than IDYA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ETNB’s TA Score shows that 6 TA indicator(s) are bullish while IDYA’s TA Score has 3 bullish TA indicator(s).

  • ETNB’s TA Score: 6 bullish, 4 bearish.
  • IDYA’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ETNB is a better buy in the short-term than IDYA.

Price Growth

ETNB (@Biotechnology) experienced а -12.34% price change this week, while IDYA (@Biotechnology) price change was +0.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.82%. For the same industry, the average monthly price growth was +4.53%, and the average quarterly price growth was +7.12%.

Reported Earning Dates

ETNB is expected to report earnings on Mar 19, 2025.

IDYA is expected to report earnings on Apr 01, 2025.

Industries' Descriptions

@Biotechnology (-0.82% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($2.64B) has a higher market cap than ETNB($946M). IDYA YTD gains are higher at: -14.306 vs. ETNB (-20.188). ETNB has higher annual earnings (EBITDA): -166.9M vs. IDYA (-187.16M). IDYA has more cash in the bank: 702M vs. ETNB (531M). IDYA has less debt than ETNB: IDYA (1.87M) vs ETNB (27.3M). IDYA has higher revenues than ETNB: IDYA (12M) vs ETNB (0).
ETNBIDYAETNB / IDYA
Capitalization946M2.64B36%
EBITDA-166.9M-187.16M89%
Gain YTD-20.188-14.306141%
P/E RatioN/AN/A-
Revenue012M-
Total Cash531M702M76%
Total Debt27.3M1.87M1,461%
TECHNICAL ANALYSIS
Technical Analysis
ETNBIDYA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
74%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 4 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 11 days ago
86%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
76%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
71%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
78%
View a ticker or compare two or three
Ad is loading...
ETNB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
IDYA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VGSIX31.450.17
+0.54%
Vanguard Real Estate Index Investor
PQIRX35.500.13
+0.37%
Pioneer Equity Income R
JTQAX14.57N/A
N/A
JHancock ESG International Equity A
BGPFX12.87-0.09
-0.68%
Baillie Gifford Developed EAFE All Cap 3
SBPYX43.30-0.68
-1.55%
ClearBridge Small Cap Growth I

ETNB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ETNB has been loosely correlated with AKRO. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ETNB jumps, then AKRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETNB
1D Price
Change %
ETNB100%
-1.49%
AKRO - ETNB
62%
Loosely correlated
-4.35%
PLRX - ETNB
47%
Loosely correlated
-0.36%
IDYA - ETNB
44%
Loosely correlated
-1.58%
MDGL - ETNB
43%
Loosely correlated
-7.05%
NTLA - ETNB
43%
Loosely correlated
-3.24%
More

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with GRI. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then GRI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
-1.58%
GRI - IDYA
54%
Loosely correlated
+2.24%
PLRX - IDYA
47%
Loosely correlated
-0.36%
INAB - IDYA
47%
Loosely correlated
-9.49%
ABSI - IDYA
44%
Loosely correlated
-13.74%
FATE - IDYA
44%
Loosely correlated
-8.82%
More